Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
NCT00085163
Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon
Phase: Phase 3
Role: Collaborator
Start: Mar 31, 2004
Completion: Not specified